Promoting High-Value Practice by Reducing Unnecessary Transfusions With a Patient Blood Management Program,JAMA Internal Medicine

当前位置： X-MOL 学术 › JAMA Intern. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Promoting High-Value Practice by Reducing Unnecessary Transfusions With a Patient Blood Management Program
JAMA Internal Medicine ( IF 22.5 ) Pub Date : 2018-01-01 , DOI: 10.1001/jamainternmed.2017.6369
Divyajot Sadana ₁ , Ariella Pratzer ₂ , Lauren J. Scher ₃ , Harry S. Saag ₂ , Nicole Adler ₂ , Frank M. Volpicelli ₂ , Moises Auron ₁ , Steven M. Frank ₄

Affiliation

Although blood transfusion is a lifesaving therapy for some patients, transfusion has been named 1 of the top 5 overused procedures in US hospitals. As unnecessary transfusions only increase risk and cost without providing benefit, improving transfusion practice is an effective way of promoting high-value care. Most high-quality clinical trials supporting a restrictive transfusion strategy have been published in the past 5 to 10 years, so the value of a successful patient blood management program has only recently been recognized. We review the most recent transfusion practice guidelines and the evidence supporting these guidelines. We also discuss several medical societies’ Choosing Wisely campaigns to reduce or eliminate overuse of transfusions. A blueprint is presented for developing a patient blood management program, which includes discussion of specific methods for optimizing transfusion practice.

中文翻译：

通过患者血液管理计划减少不必要的输血来促进高价值实践

尽管输血对某些患者来说是一种挽救生命的疗法，但输血已被列为美国医院最常使用的 5 种手术之一。由于不必要的输血只会增加风险和成本而不会带来收益，因此改善输血实践是促进高价值护理的有效方法。大多数支持限制性输血策略的高质量临床试验都是在过去 5 到 10 年发表的，因此成功的患者血液管理计划的价值直到最近才得到认可。我们回顾了最新的输血实践指南和支持这些指南的证据。我们还讨论了几个医学协会为减少或消除过度输血而发起的“明智选择”运动。提出了开发患者血液管理程序的蓝图，

更新日期：2018-01-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11